Aggregator

Last fall, Dean Srikant Datar announced the formation of four working groups to address current issues on campus: Antisemitism, Islamophobia and Anti-Arabism, Classroom Culture and Norms, and Free Expression and Community Values. Below is our conversation with the faculty co-chairs of the Islamophobia and Anti-Arabism Working Group, Hakeem (Keem) Belo-Osagie and Kristin Mugford, about their priorities, discoveries, and plans for making HBS feel supportive and inclusive for Arab and Muslim members of the School's community.

Every year, the HBS MBA Admissions team hosts a fully virtual, open-enrollment program intended for undergraduates to get a peek at the MBA experience. Over three days, participants engage with different offices and community members to get an understanding of how an MBA can support their future career goals. This year’s programming included eight case discussions and various panel discussions and sessions with students, faculty, and alumni on topics such as diverse perspectives, making a difference in the world through business, how to increase your personal brand, and authentic leadership.

The Executive Fellows program seeks to leverage the expertise of outstanding practitioners—many of whom are alumni—to enhance teaching and learning at the School. Fellows partner with at least one HBS faculty member to bring their business experience to the HBS community.

At a glance: Study finds people with schizophrenia and older adults have strikingly similar sets of changes in gene activity in two types of brain cells. Findings suggest a shared biological basis for cognitive impairment in schizophrenia and aging and point to new strategies for treating it. The work also implicates a cell type not previously known to affect genetic vulnerability for schizophrenia. Brain tissue samples from people with schizophrenia and from older adults have strikingly similar sets of changes in gene activity in two types of brain cells, suggesting a common biological basis...

Harvard Business School (HBS) is delighted to announce the 2023-2025 exhibition supported by the C. Ludens Ringnes Sculpture Collection at Harvard Business School, which features a sculpture by artist Ursula von Rydingsvard, one of the few women working in monumental sculpture.

At a glance: Revealing the inner workings of drug-resistant bacteria is informing development of much-needed new antibiotics. Experimental drug now in clinical trials takes a new approach to defeating deadly A. baumannii infections. Collaboration between basic research scientists and the pharmaceutical industry drove the advances. Harvard University chemist Daniel Kahne has spent much of his career studying the fundamentals of how bacteria thrive and evade attack. His lab has a special interest in gram-negative bacteria, which have an outer membrane that many antibiotics cannot cross. Get more...